GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Inovio Biomedical Corporation (INO) [hlAlert]

Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. Inovio develops deoxyribonucleic acid (DNA) delivery solutions based on electroporation, which uses brief, controlled electrical pulses to
create temporary pores in cell membranes and enable increased cellular uptake of a useful biopharmaceutical. Once the DNA vaccine enters a cell, it can then express the proteins it was encoded to produce. Inovio has multiple systems designed to create different electroporation conditions for different applications consists of two documents: a pulse generator and an applicator that is inserted into selected tissue. The Company?s subsidiaries include Genetronics, Inc., Inovio AS and Inovio Asia Pte. Ltd. In June 2009, Inovio completed its merger with VGX Pharmaceuticals.
.
( Total: 11 Current Stock Recommendations )
Inovio Biomedical Corporation   (11)
Hold Buy 91%
Related companies
Zoll Medical ...   (7)
Buy 100%
Endologix Inc   (9)
Buy 100%
Msa Safety Inc.   (6)
Hold 17% Buy 83%
Smith & Nephew ...   (21)
Sell Hold 38% Buy 48%
Sonosite, Inc.   (4)
Hold 50% Buy 50%
Steris Corporation   (9)
Hold 33% Buy 67%
Synovis Life ...   (4)
Sell 25% Hold 50% Buy 25%
Wright Medical ...   (20)
Hold 45% Buy 55%
Ev3 Inc.   (15)
Hold 53% Buy 47%
Volcano Corporation   (24)
Hold 46% Buy 54%
Filter by Gains:   
  
Rating:
Buy INO
up 168.46 %

Rating:
Buy INO
up 168.46 %

Rating:
Buy INO
down 5.29 %

Rating:
Buy INO
down 46.22 %

Rating:
Buy INO
up 217.27 %

Rating:
Buy INO
up 168.46 %

Rating:
Buy INO
down 31.29 %

Rating:
Hold INO

Rating:
Buy INO
up 168.46 %

Rating:
Buy INO
up 171.69 %

Rating:
Buy INO
up 168.46 %

Rating:
Buy INO
up 142.36 %

Rating:
Buy INO
up 61.57 %

Rating:
Buy INO
up 26.44 %

Rating:
Buy INO
up 93.88 %

Your Recent Stocks
SymbolLastChange
INO 6.30 down  -9.74 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy